Pulmonary vascular complications of chronic liver disease: Pathophysiology, imaging, and treatment

Annals of Thoracic Medicine

Volumn 6, Issue 2, 2011, Pages 57-65

  Khan, Ali Nawaz ^a   Al Jahdali, Hamdan ^b   Abdullah, Khalid ^c   Irion, Klaus L ^d   Sabih, Quratulain ^e   Gouda, Alaa ^b  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^e Department of Internal Medicine ^*  (United States)

Author keywords

Hepatopulmonary syndrome; portopulmonary hypertension; pulmonary arteriovenous shunts; Yttrium 90 microsphere embolization hepatocellular carcinoma

Indexed keywords

ALMITRINE DIMESILATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; DIURETIC AGENT; ILOPROST; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID; SILDENAFIL; SOMATOSTATIN;

CHRONIC LIVER DISEASE; CLINICAL FEATURE; COIL EMBOLIZATION; DISEASE ASSOCIATION; HEPATOPULMONARY SYNDROME; HUMAN; LIVER TRANSPLANTATION; LUNG ANGIOGRAPHY; PATHOGENESIS; PORTOPULMONARY HYPERTENSION; PROGNOSIS; PULMONARY VASCULAR DISEASE; REVIEW; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

EID: 79954540026     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: 10.4103/1817-1737.78412     Document Type: Review

References (61)

1. Krowka MJ, Cortese DA. Hepatopulmonary syndrome: An evolving perspective in the era of liver transplantation. Hepatology 1990;11:138-42 (Pubitemid 20075114)
2. Kennedy TC, Knudson RJ. Exercise-aggravated hypoxemia and orthodexia in cirrhosis. Chest 1997;72:305-9
3. Krowka MJ, Cortese DA. Hepatopulmonary syndrome: Current concepts in diagnostic and therapeutic considerations. Chest 1994;105:1528-37. (Pubitemid 24152616)
4. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995;109:1283-8.
5. Castro M, Krowka MJ. Hepatopulmonary syndrome: A pulmonary vascular complication of liver disease. Clin Chest Med 1996;17:35-48. (Pubitemid 26100792)
6. de Macdo LG, Lopes EP. Hepatopulmonary syndrome: An update. Sao Paulo Med J 2009;127:223-30
7. Bruix J, Bosch J, Kravetz D, Mastai R, Rods J. Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver. Gastroenterology 1985;88:430-5 (Pubitemid 15194706)
8. Cremona G, Higenbottam TW, Mayoral V, Alexander G, Demoncheaux E, Borland C, et al. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J 1995;8:1883-5
9. Davis HH 2nd, Schwartz DJ, Lefrak SS, Susman N, Schainker BA. Alveolar-capillary oxygen disequilibrium in hepatic cirrhosis. Chest 1978;73:507-11. (Pubitemid 8364897)
10. Krowka M, Wiseman G, Burnett O. Hepatopulmonary syndrome: A prospective study of relationships between severity of liver disease, PaO2 response to 100% oxygen, and brain uptake after TC 99m MAA lung scanning. 2000. p. 615-624
11. Hedenstierna G, Soderman C, Eriksson LS, Wahren J. Ventilation perfusion inequality in patients with non-alcoholic liver cirrhosis. Eur Respir J 1991;4:711-7.
12. Hopkins WE, Waggoner AD, Barzilai B. Frequency and significance of intrapulmonary right-to-left shunting in end-stage hepatic disease. Am J Cardiol 1992;70:516-9.
13. Whyte MK, Hughes JM, Peters AM, Ussov W, Patel S, Burroughs AK. Analysis of intrapulmonary right to left shunt in the hepatopulmonary syndrome. J Hepatol 1998;29:85-93. (Pubitemid 28307987)
14. Brussino L, Bucca C, Morello M, Scappaticci E, Mauro M, Rolla G. Effect on dyspnoea and hypoxemia of inhaled NG-nitro-L-arginine methyl ester inhepatopulmonary syndrome. Lancet 2003;362:43-4. (Pubitemid 36835821)
15. Zhang HY, Han DW, Wang XG, Zhao YC, Zhou X, Zhao HZ. Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome. World J Gastroenterol 2005;11:567-72. (Pubitemid 40185596)
16. Rabiller A, Nunes H, Lebrec D, Tazi KA, Wartski M, Dulmet E, et al. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med 2002;166:514-7.
17. Gmez FP, Barber JA, Roca J, Burgos F, Gistau C, Rodrguez-Roisin R. Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology 2006;43:1084-91. (Pubitemid 43724632)
18. Seward JB, Hayes DL, Smith HC, Williams DE, Rosenow EC 3rd, Reeder GS, et al. Platypnea-orthodeoxia: Clinical profile, diagnostic work-up, management and report of 7 cases. Mayo Clin Proc 1984;59:221.
19. Lima BL, Franca AV, Pazin-Filho A, Arajo WM, Martinez JA, Maciel BC, et al. Frequency, clinical characteristics, and respiratory parameters of hepatopulmonary syndrome. Mayo Clin Proc 2004;79:42-8 (Pubitemid 38018583)
20. Rodriguez-Roisin R, Roca J, Agusti AG, Mastai R, Wagner PD, Bosch J. Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis 1987;135:1085-92 (Pubitemid 18021494)
21. Fallon MB, Krowka MJ, Brown RS, Trotter JF, Zacks S, Roberts KE, et al. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology 2008;135:1168-75.
22. Swanson KL, Weiner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology 2005;41:1122-9. (Pubitemid 40593920)
23. Schenk P, Fuhrmann V, Madl C, Funk G, Lehr S, Kandel O, et al. Hepatopulmonary syndrome: Prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 2002;51:853-9. (Pubitemid 35408608)
24. McAdams HP, Erasmus J, Crockett R, Mitchell J, Godwin JD, McDermott VG. The hepatopulmonary syndrome: Radiologic findings in 10 patients. AJR Am J Roentgenol 1996;166:1379-85. (Pubitemid 26160594)
25. El-Shabrawl MH, Omran S, Wageeh S, Isa M, Okasha S, Mohsen NA, et al. 99mTechnitium-macroaggregated albumin perfusion lung scan versus contrast enhanced echocardiography in the diagnosis of the hepatopulmonary syndrome in children with chronic liver disease. Eur J Gastroenterol Hepatol 2010;22:1006-12.
26. Shub C, Tajik AJ, Seward JB, Dines DE. Detecting intrapulmonary right-to-left shunt with contrast echocardiography: Observations in a patient with diffuse pulmonary arteriovenous fistulas. Mayo Clin Proc 1976;51:81-4.
27. Karabulut A, Iltumur K, Yalcin K, Toprak N. Hepatopulmonary syndrome and right ventricular diastolic functions: An echocardiographic examination. Echocardiography 2006;23:271-8.
28. Vedrinne JM, Duperret S, Bizollon T, Magnin C, Motin J, Trepo C, et al. Comparison of transoesophageal and transthoracic contrast echocardiography for detection of an intrapulmonary shunt in liver disease. Chest 1997;111:1236-40. (Pubitemid 27200077)
29. Scott VL, Dodson SF, Kang Y. The hepatopulmonary syndrome. Surg Clin North Am 1999;79:23-41. (Pubitemid 29100484)
30. Castro M, Krowka MJ. Hepatopulmonary syndrome: A pulmonary vascular complication of liver disease. Clin Chest Med 1996;17:35-48. (Pubitemid 26100792)
31. Suga K, Kawakami Y, Iwanaga H, Tokuda O, Matsunaga N. Findings of hepatopulmonary syndrome on breath-hold perfusion SPECT-CT fusion images. Ann Nucl Med 2009;23:413-9.
32. Yigit IP, Hacievliyagil SS, Seckin Y, Oner RI, Karincaoglu M. The relationship between severity of liver cirrhosis and pulmonary function tests. Dig Dis Sci 2008;53:1951-6.
33. Saad NE, Lee DE, Waldman DL, Saad W. Pulmonary arterial coil embolization for the management of persistent type I hepatopulmonary syndrome after liver transplantation. J Vasc Interv Radiol 2007;18:1576-80. (Pubitemid 350151876)
34. Krowka MJ, Dickson ER, Cortese DA. Hepatopulmonary syndrome: Clinical observations and lack of therapeutic response to somatostatin analogue. Chest 1993;104:515-21. (Pubitemid 23229526)
35. Milhe F, Reynaud-Gaubert M, Magnan A, Delpierreb S, Vervloet D. Oxygenation improvement with almitrine bismesylate in the hepatopulmonary syndrome. Respir Med Extra 2006;2:81-4. (Pubitemid 44442020)
36. Krug S, Seyfarth HJ, Hagendorff A, Wirtz H. Inhaled iloprost for hepatopulmonary syndrome: Improvement of hypoxemia. Eur Gastroenterol Hepatol 2007;19:1140-3. (Pubitemid 350125387)
37. Abrams GA, Fallon MB. Treatment of hepatopulmonary syndrome with Allium sativum L. (garlic): A pilot trial. J Clin Gastroenterol 1998;27:232-5. (Pubitemid 28495842)
38. Selim KM, Akriviadis EA, Zuckerman E, Chen D, Reynolds TB. Transjugular intrahepatic portosystemic shunt: A successful treatment for hepatopulmonary syndrome. J Am Coll Gastroenterol 1998;93:455-8. (Pubitemid 29068356)
39. Martinez-Palli G, Drake BB, Garcia-Pagan JC, Barbera JA, Arguedas MR, Rodriguez-Roisin R, et al. Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome. World J Gastroenterol 2005;11:6858-62. (Pubitemid 43092461)
40. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Kobayashi N. Segmental obstruction of the hepatic inferior vena cava treated with transluminal angioplasty. Radiology 1983;149:91-6. (Pubitemid 13006812)
41. Arguedas M, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003;37:192-7. (Pubitemid 36042160)
42. Cao X, He N, Sun J, Tan J, Zhang C, Yang J, et al. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer. Chin Med J (Engl) 1999;112:430-2.
43. Troy PJ. Review: Portopulmonary hypertension: Challenges in diagnosis and management. Ther Adv Gastroenterol 2009;2:281-6.
44. Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991;100:520-8.
45. De BK, Pal A, Santra A, Das TK, Biswas P, Agarwal PK, et al. Primary pulmonary hypertension in non-cirrhotic portal fibrosis. Indian J Gastroenterol 1997;16:85-7.
46. Ohno T, Muneuchi J, Ihara K, Yuge T, Kanaya Y, Yamaki S, et al. Pulmonary hypertension in patients with congenital portosystemic venous shunt: A previously unrecognized association. Pediatrics 2008;121:e892-9.
47. Herv P, Lebrec D, Brenot F, Simonneau G, Humbert M, Sitbon O, et al. Pulmonary arterial hypertension in portal hypertension. Eur Respir J 1998;11:1153-66.
48. Fallon MB, Krowka MJ, Brown RS, Trotter JF, Peter I, Tighiourt H, et al. Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am J Respir Crit Care Med 2009;179:835-42.
49. Robalino BD, Moodie DS. Association between primary pulmonary hypertension and portal hypertension: Analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. J Am Coll Cardiol 1991;17:492-8.
50. Mandell MS, Groves BM. Pulmonary hypertension in chronic liver disease. Clin Chest Med 1996;17:17-33 (Pubitemid 26100791)
51. The International Primary Pulmonary Hypertension Study (IPPHS). Chest1994;105:37S-41S.
52. Tan RT, Kuzo R, Goodman LR, Siegel R, Haasler GB, Presberg KW. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Chest 1998;113:1250-6. (Pubitemid 28223812)
53. Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: The ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 1999;14:270-8. (Pubitemid 29470994)
54. Provencher S, Herve P, Jais X, Lebrec D, Humbert M, Simonneau G, et al. Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension. Gastroenterology 2006;130:120-6. (Pubitemid 43049842)
55. Kuo PC, Johnson LB, Plotkin JS, Howell CD, Bartlett ST, Rubin LJ. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation 1997;63:604-6. (Pubitemid 27102632)
56. Anderson JR, Nawarskas JJ. Pharmacotherapeutic management of pulmonary arterial hypertension. Cardiol Rev 2010;18:148-62
57. Reichengerger F, Voswinckel R, Steveling E, Enke B, Kreckel A, Olschewski H, et al. Sildenafil treatment for portopulmonary hypertension. Eur Respir J 2006;28:563-7. (Pubitemid 44794671)
58. Porres-Aguilar M, Zuckerman MJ, Figueroa-Casas JB, Krowka MJ. Portopulmonary hypertension: State of the art. Ann Hepatol 2008;7:321-30.
59. Iqbal CW, Krowka MJ, Pham TH, Freese DK, El Youssef M, Ishitani MB. Liver transplantation for pulmonary vascular complications of pediatric end-stage liver disease. J PediatrSurg 2008;43:1813-20.
60. Swanson KL, Krowka MJ. Screen for portopulmonary hypertension, especially in liver transplant candidates. Cleveland Clin J Med 2008;75:121-36.
61. Sulica R, Emre S, Poon M. Medical management of portopulmonary hypertension and right heart failure prior to living-related liver transplantation. Congest Heart Fail 2004;10:192-4.